Oral magnesium supplements and insulin resistance in individuals with diabetes and pre-diabetes: an updated systematic review and meta-analysis of randomized controlled trials
Amiri A, Seighali F, Gholami-Chahkand MS, Jannat B, Seighali N
BMC nutrition · 1 cita
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Revisión sistemática (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2026-07-09 · BMC Nutr
- Editorial
- BioMed Central
- Citado
- 1 cita · más que el 93% de estudios similares · 2.6× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 0 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY-NC-ND
- Áreas de investigación
- Magnesium in Health and Disease · Parathyroid Disorders and Treatments · Magnesium Alloys: Properties and Applications
- Palabras clave
- Prediabetes, Randomized controlled trial, Insulin resistance, Diabetes mellitus, Meta-analysis, Clinical nutrition, Placebo, Population
5 autores
- Aryana Amiri🇮🇷Ministry of Health and Medical Education; Iran Nanohealth Committee Food and Drug Organization
- Fatemeh Jodeiri Entezari🇮🇷Ministry of Health and Medical Education; Iran Nanohealth Committee Food and Drug Organization; Tehran University of Medical Sciences
- Mohammad Sadra Gholami Chahkand🇮🇷Golestan University; Ministry of Health and Medical Education; Golestan University of Medical Sciences; Iran Nanohealth Committee Food and Drug Organization
- Behrooz Jannat🇮🇷 · autor de correspondenciaMinistry of Health and Medical Education
- Niloofar Seighali🇮🇷 · autor de correspondenciaJahrom University of Medical Sciences; Ministry of Health and Medical Education; Iran Nanohealth Committee Food and Drug Organization
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Diabetes is a common health challenge. Previous studies have established that diabetes is often associated with low circulating magnesium status. As evidence from randomized controlled trials (RCTs) on the effect of magnesium supplementation on insulin resistance remains inconsistent, and the influence of baseline status is not fully understood, this systematic review and meta-analysis evaluated the effects of magnesium supplements, compared with placebo, on insulin resistance in individuals with diabetes and pre-diabetes.
Methods
A comprehensive search based on the PRISMA 2020 guidelines was conducted in PubMed, Web of Science, and Scopus until 24 April 2026. Randomized controlled trials with a population of individuals with diabetes and pre-diabetes that received any magnesium supplements compared to a placebo group, evaluating insulin and the HOMA-IR index as the primary outcome, were included in our study. Secondary outcomes were serum magnesium level, HbA1c, and fasting blood glucose (FBG). We pooled data using a random-effects model to estimate changes in outcomes. Subgroup analyses were conducted based on dosage (> 250 and ≤ 250 mg/day) and follow-up duration (under or over 12 weeks). Meta-regression, publication bias, and sensitivity analysis were performed as well.
Results
Fifteen RCTs involving 1,085 participants met the criteria. Overall, the oral magnesium supplementation did not result in a statistically significant change in insulin levels (MD = - 1.73; 95% CI: -3.73 to 0.27; p-value = 0.09) and HOMA-IR (MD = - 0.74; 95% CI: -1.58 to 0.09; p-value = 0.08) in people with diabetes. Similar non-significant findings were observed in individuals with prediabetes (p > 0.05). However, meta-regression analysis demonstrated that baseline insulin level and HOMA-IR index significantly modified the intervention effect (p = 0.01), suggesting differential responsiveness across patient subgroups. No significant associations were observed for baseline HbA1c, fasting blood glucose, magnesium levels, age, or BMI. Subgroup analysis based on doses and duration of follow-up did not change the significance of the result.
Conclusion
Magnesium supplementation does not appear to improve insulin resistance in individuals with diabetes or prediabetes significantly. However, its effects may depend on baseline insulin status, highlighting the need for targeted interventions in individuals with higher insulin resistance. Future well-designed trials with larger sample sizes are needed to clarify baseline insulin effects.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC-ND).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.